REGENERON PHARMACEUTICALS

Ticker: REGN CUSIP: 75886F107 Class: COM

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 45,200 Value ($000) $47,516 Avg Close $1106.73 Range $1002.85 - $1204.52

Q2 2024

Shares 22,800 Value ($000) $23,963 Avg Close $964.05 Range $870.40 - $1075.21

Q1 2024

Shares 22,800 Value ($000) $21,945 Avg Close $945.64 Range $866.58 - $992.82

Q4 2023

Shares 13,500 Value ($000) $11,857 Avg Close $818.96 Range $764.95 - $894.90

Q3 2023

Shares 13,500 Value ($000) $11,110 Avg Close $781.58 Range $684.72 - $842.83

Q2 2023

Shares 13,500 Value ($000) $9,700 Avg Close $766.75 Range $681.03 - $832.93

Q1 2023

Shares 24,000 Value ($000) $19,720 Avg Close $750.05 Range $664.32 - $830.39

Q2 2022

Shares 22,200 Value ($000) $13,123 Avg Close $646.43 Range $535.04 - $743.30

Q3 2021

Shares 13,560 Value ($000) $8,206 Avg Close $617.39 Range $551.89 - $682.83

Q2 2020

Shares 30,900 Value ($000) $19,271 Avg Close $564.49 Range $473.82 - $642.77

Q1 2020

Shares 17,200 Value ($000) $8,399 Avg Close $410.21 Range $326.32 - $515.14

Q4 2019

Shares 209,300 Value ($000) $78,588 Avg Close $334.59 Range $270.76 - $380.14

Q3 2019

Shares 228,100 Value ($000) $63,275 Avg Close $294.28 Range $269.87 - $318.99

Q2 2019

Shares 215,800 Value ($000) $67,545 Avg Close $331.08 Range $293.64 - $413.60

Q1 2019

Shares 214,800 Value ($000) $88,201 Avg Close $409.51 Range $363.99 - $439.56

Q4 2018

Shares 222,100 Value ($000) $82,954 Avg Close $364.00 Range $325.77 - $407.74

Q3 2018

Shares 394,400 Value ($000) $159,353 Avg Close $378.49 Range $340.69 - $414.19

Q2 2018

Shares 372,500 Value ($000) $128,509 Avg Close $311.03 Range $280.34 - $347.31

Q1 2018

Shares 962,900 Value ($000) $331,584 Avg Close $345.90 Range $311.80 - $394.59

Q4 2017

Shares 854,600 Value ($000) $321,295 Avg Close $402.77 Range $351.19 - $474.37

Q3 2017

Shares 572,770 Value ($000) $256,097 Avg Close $473.21 Range $424.12 - $523.22

Q2 2017

Shares 466,770 Value ($000) $229,249 Avg Close $435.19 Range $358.01 - $540.55

Q1 2017

Shares 378,170 Value ($000) $146,545 Avg Close $368.62 Range $338.21 - $399.00

Q4 2016

Shares 355,300 Value ($000) $130,427 Avg Close $378.17 Range $323.56 - $450.46

Q3 2016

Shares 355,300 Value ($000) $142,838 Avg Close $398.92 Range $346.51 - $441.54

Q2 2016

Shares 509,900 Value ($000) $178,072 Avg Close $383.00 Range $327.27 - $431.54

Q1 2016

Shares 533,000 Value ($000) $192,115 Avg Close $409.79 Range $347.04 - $529.97

Q4 2015

Shares 483,000 Value ($000) $262,206 Avg Close $538.82 Range $445.63 - $589.32

Q3 2015

Shares 487,700 Value ($000) $226,849 Avg Close $534.07 Range $433.12 - $602.59

Q2 2015

Shares 461,800 Value ($000) $235,578 Avg Close $485.93 Range $431.08 - $541.00

Q1 2015

Shares 421,800 Value ($000) $190,434 Avg Close $421.46 Range $390.83 - $492.77

Q4 2014

Shares 390,200 Value ($000) $160,080 Avg Close $391.09 Range $318.29 - $435.23

Q3 2014

Shares 369,600 Value ($000) $133,248 Avg Close $333.32 Range $283.49 - $367.27

Q2 2014

Shares 326,600 Value ($000) $92,255 Avg Close $294.74 Range $268.01 - $318.24

Q1 2014

Shares 539,000 Value ($000) $161,851 Avg Close $306.39 Range $261.52 - $350.55

Q4 2013

Shares 738,800 Value ($000) $203,347 Avg Close $286.03 Range $256.27 - $317.74

Q3 2013

Shares 513,100 Value ($000) $160,534 Avg Close $261.58 Range $224.53 - $318.07

Q2 2013

Shares 351,100 Value ($000) $78,955 Avg Close $231.58 Range $176.14 - $282.42

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	45,200	$47,516	$1106.73	$1002.85 - $1204.52
Q2 2024	22,800	$23,963	$964.05	$870.40 - $1075.21
Q1 2024	22,800	$21,945	$945.64	$866.58 - $992.82
Q4 2023	13,500	$11,857	$818.96	$764.95 - $894.90
Q3 2023	13,500	$11,110	$781.58	$684.72 - $842.83
Q2 2023	13,500	$9,700	$766.75	$681.03 - $832.93
Q1 2023	24,000	$19,720	$750.05	$664.32 - $830.39
Q2 2022	22,200	$13,123	$646.43	$535.04 - $743.30
Q3 2021	13,560	$8,206	$617.39	$551.89 - $682.83
Q2 2020	30,900	$19,271	$564.49	$473.82 - $642.77
Q1 2020	17,200	$8,399	$410.21	$326.32 - $515.14
Q4 2019	209,300	$78,588	$334.59	$270.76 - $380.14
Q3 2019	228,100	$63,275	$294.28	$269.87 - $318.99
Q2 2019	215,800	$67,545	$331.08	$293.64 - $413.60
Q1 2019	214,800	$88,201	$409.51	$363.99 - $439.56
Q4 2018	222,100	$82,954	$364.00	$325.77 - $407.74
Q3 2018	394,400	$159,353	$378.49	$340.69 - $414.19
Q2 2018	372,500	$128,509	$311.03	$280.34 - $347.31
Q1 2018	962,900	$331,584	$345.90	$311.80 - $394.59
Q4 2017	854,600	$321,295	$402.77	$351.19 - $474.37
Q3 2017	572,770	$256,097	$473.21	$424.12 - $523.22
Q2 2017	466,770	$229,249	$435.19	$358.01 - $540.55
Q1 2017	378,170	$146,545	$368.62	$338.21 - $399.00
Q4 2016	355,300	$130,427	$378.17	$323.56 - $450.46
Q3 2016	355,300	$142,838	$398.92	$346.51 - $441.54
Q2 2016	509,900	$178,072	$383.00	$327.27 - $431.54
Q1 2016	533,000	$192,115	$409.79	$347.04 - $529.97
Q4 2015	483,000	$262,206	$538.82	$445.63 - $589.32
Q3 2015	487,700	$226,849	$534.07	$433.12 - $602.59
Q2 2015	461,800	$235,578	$485.93	$431.08 - $541.00
Q1 2015	421,800	$190,434	$421.46	$390.83 - $492.77
Q4 2014	390,200	$160,080	$391.09	$318.29 - $435.23
Q3 2014	369,600	$133,248	$333.32	$283.49 - $367.27
Q2 2014	326,600	$92,255	$294.74	$268.01 - $318.24
Q1 2014	539,000	$161,851	$306.39	$261.52 - $350.55
Q4 2013	738,800	$203,347	$286.03	$256.27 - $317.74
Q3 2013	513,100	$160,534	$261.58	$224.53 - $318.07
Q2 2013	351,100	$78,955	$231.58	$176.14 - $282.42